$Beyond Air (XAIR.US)$ NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy Monday, 24th March at 4:05 pm First-in-human studies anticipated to begin in 2026 Engaged a top tier U.S. based contract manufacturer to ensure the highest standards of quality Currently in the advanced stages of formulation development for subcutaneous injection, with plans for an oral formulation BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- NeuroNOS, a pioneering biopharmaceu...
Tonyco : nice, so wait for 2026 at least , 2030ish for bigtimes...